Ganda, O. P., Plutzky, J., Sanganalmath, S. K., Bujas‐Bobanovic, M., Koren, A., Mandel, J., . . . Leiter, L. A. (2018). Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Diabetes Obes Metab.
Citação norma ChicagoGanda, Om P., Jorge Plutzky, Santosh K. Sanganalmath, Maja Bujas‐Bobanovic, Andrew Koren, Jonas Mandel, Alexia Letierce, and Lawrence A. Leiter. "Efficacy and Safety of Alirocumab Among Individuals With Diabetes Mellitus and Atherosclerotic Cardiovascular Disease in the ODYSSEY Phase 3 Trials." Diabetes Obes Metab 2018.
ציטוט MLAGanda, Om P., et al. "Efficacy and Safety of Alirocumab Among Individuals With Diabetes Mellitus and Atherosclerotic Cardiovascular Disease in the ODYSSEY Phase 3 Trials." Diabetes Obes Metab 2018.